Cosopt
From Wikipedia, the free encyclopedia
Cosopt is a drug for lowering pressure in the eye to normal levels, and a treatment for glaucoma. Cosopt is a combination of two chemicals: dorzolamide hydrochloride and timolol maleate. It gained Food and Drug Administration (FDA) approval in April 1998, and is supplied by Merck.
[edit] External links
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
 |
This eye article is a stub. You can help Wikipedia by expanding it. |
